Former FDA head Stephen Hahn joins radiopharmaceuticals startup as CEO

Taking stock of the drug industry, from the lab to the medicine chest

August 20, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

GRAEME JENNINGS/POOL/AFP via Getty Images STAT+ | Former FDA head Stephen Hahn joins radiopharmaceuticals startup as CEO Nucleus RadioPharma hopes to expand access to therapies in a field that has proven challenging for other companies. By Allison DeAngelis STAT+ | GLP-1s, cancer care are driving higher employer health care costs in 2026 A new survey shows employer health insurance costs will jump 9% in 2026. GLP-1 drugs, cancer, and mental health top the list of drivers. By Tara Bannow Opinion: Republicans and Democrats must agree: Americans deserve price transparency in health care Price transparency is a bipartisan health fix at a time when Americans are seeking real solutions that bridge political divides. By Roger Marshall

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser